0001140361-14-038522.txt : 20141017
0001140361-14-038522.hdr.sgml : 20141017
20141017204205
ACCESSION NUMBER: 0001140361-14-038522
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141015
FILED AS OF DATE: 20141017
DATE AS OF CHANGE: 20141017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RESMED INC
CENTRAL INDEX KEY: 0000943819
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 980152841
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 9001 SPECTRUM CENTER BLVD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92123
BUSINESS PHONE: 8587462400
MAIL ADDRESS:
STREET 1: 9001 SPECTRUM CENTER BLVD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Farrell Michael J.
CENTRAL INDEX KEY: 0001485164
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15317
FILM NUMBER: 141162851
MAIL ADDRESS:
STREET 1: C/O REMED INC
STREET 2: 9001 SPECTRUM CTR. BLVD.
CITY: SAN DIEGO,
STATE: CA
ZIP: 92123
FORMER NAME:
FORMER CONFORMED NAME: Farrell Michael
DATE OF NAME CHANGE: 20100224
4
1
doc1.xml
FORM 4
X0306
4
2014-10-15
0
0000943819
RESMED INC
RMD
0001485164
Farrell Michael J.
RESMED INC.
9001 SPECTRUM CENTER BLVD
SAN DIEGO
CA
92123
0
1
0
0
Chief Executive Officer
ResMed Common Stock
2014-10-15
4
M
0
3200
21.675
A
147046.744
D
ResMed Common Stock
2014-10-15
4
S
0
3200
46.612
D
143846.744
D
ResMed Common Stock Options
21.675
2014-10-15
4
M
0
3200
0
D
2006-10-01
2015-10-01
ResMed Common Stock
3200
300
D
The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.
Represents date options first became exercisable. Options vested 1/3 on the anniversary of the grant.
This transaction was executed in multiple trades at prices ranging from $46.36 to $46.77. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.
Michael J. Farrell, Chief Executive Officer
2014-10-17